Alerts will be sent to your verified email
Verify EmailMOREPENLAB
Morepen Laboratories
|
SMS Pharmaceuticals
|
Solara Active Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Global DMFs filed
|
211.0 . | n/a | n/a |
R&D as a % of Total Sales
|
0.87 % | 2.4 % | n/a |
Financials
|
|||
5 yr Average ROE
|
13.43 % | 9.06 % | -10.41 % |
5yr average Equity Multiplier
|
1.68 | 1.9 | 1.99 |
5yr Average Asset Turnover Ratio
|
1.29 | 0.64 | 0.54 |
5yr Avg Net Profit Margin
|
5.93 % | 7.28 % | -7.28 % |
Price to Book
|
2.57 | 4.28 | 2.98 |
P/E
|
32.04 | 37.45 | 132.81 |
5yr Avg Cash Conversion Cycle
|
12.78 Days | 93.25 Days | 28.67 Days |
Inventory Days
|
54.64 Days | 116.73 Days | 111.94 Days |
Days Receivable
|
65.45 Days | 93.46 Days | 95.97 Days |
Days Payable
|
96.29 Days | 85.64 Days | 146.85 Days |
5yr Average Interest Coverage Ratio
|
39.11 | 4.77 | 0.25 |
5yr Avg ROCE
|
15.77 % | 12.12 % | 2.1 % |
5yr Avg Operating Profit Margin
|
8.68 % | 17.98 % | 9.63 % |
5 yr average Debt to Equity
|
0.04 | 0.53 | 0.7 |
5yr CAGR Net Profit
|
3.98 % | 9.56 % | -69.98 % |
5yr Average Return on Assets
|
7.67 % | 4.75 % | -3.67 % |
Shareholdings
|
|||
Promoter Holding
|
35.65 % | 66.26 % | 42.01 % |
Share Pledged by Promoters
|
0.0 | 32.49 % | 38.95 % |
Change in Promoter Holding (3 Yrs)
|
-1.09 % | 2.09 % | 1.61 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 3.03 % | -1.56 % |
Morepen Laboratories
|
SMS Pharmaceuticals
|
Solara Active Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|